GeneDx Holdings (WGS) Gross Margin (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Gross Margin data on file, last reported at 66.71% in Q1 2026.

• Gross Margin for Q1 2026 came in at 66.71%, down 42.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 69.56% (up 429.0% YoY), and the FY2025 annual result was 69.74%, up 610.0% from the prior year.
• Gross Margin declined to 66.71% in Q1 2026 per WGS's latest filing, from 69.65% in the prior quarter.
• Over five years, Gross Margin peaked at 72.4% in Q3 2025 and troughed at 81.83% in Q2 2022.
• A 5-year average of 40.6% and a median of 59.93% in 2024 frame the typical range for Gross Margin.
• The sharpest annual moves came in 2022 and 2023: Gross Margin tumbled 7936 bps in 2022, then jumped 12034 bps in 2023.
• A 5-year view of Gross Margin shows it stood at 26.61% in 2022, then surged by 301 bps to 53.56% in 2023, then gained by 29 bps to 69.22% in 2024, then gained by 1 bps to 69.65% in 2025, then retreated by 4 bps to 66.71% in 2026.
• Business Quant data shows WGS's Gross Margin at 66.71% in Q1 2026, 69.65% in Q4 2025, and 72.4% in Q3 2025.